Business Description
MDxHealth SA
NAICS : 541380
SIC : 8071
ISIN : BE0974461940
Total Employee Number:
364Description
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | -0.13 | |||||
Debt-to-Equity | -5.23 | |||||
Debt-to-EBITDA | -12.26 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.03 | |||||
Beneish M-Score | -3.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.6 | |||||
3-Year EBITDA Growth Rate | 49.8 | |||||
3-Year EPS without NRI Growth Rate | 42.7 | |||||
3-Year FCF Growth Rate | 69.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 29 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.41 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 1.04 | |||||
Days Inventory | 49.32 | |||||
Days Sales Outstanding | 51.59 | |||||
Days Payable | 83.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46.6 | |||||
Shareholder Yield % | -124.91 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.75 | |||||
Operating Margin % | -16.3 | |||||
Net Margin % | -29.9 | |||||
EBITDA Margin % | -7.79 | |||||
FCF Margin % | -1.93 | |||||
OCF Margin % | -0.98 | |||||
ROA % | -21.31 | |||||
ROIC % | -13.48 | |||||
3-Year ROIIC % | 72.49 | |||||
ROC (Joel Greenblatt) % | -139.75 | |||||
ROCE % | -17.71 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.2 | |||||
EV-to-EBIT | -4.32 | |||||
EV-to-EBITDA | -9.77 | |||||
EV-to-Revenue | 0.76 | |||||
EV-to-Forward-Revenue | 1.14 | |||||
EV-to-FCF | -40.35 | |||||
Price-to-GF-Value | 0.19 | |||||
Earnings Yield (Greenblatt) % | -23.15 | |||||
FCF Yield % | -9.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MDxHealth SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 95.36 | ||
| EPS (TTM) (€) | -0.549 | ||
| Beta | 0.4065 | ||
| 3-Year Sharpe Ratio | -0.27 | ||
| 3-Year Sortino Ratio | -0.39 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 3.01983 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 3.01983 - 3.01983 | ||
| Shares Outstanding (Mil) | 51.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MDxHealth SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MDxHealth SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 | In 113 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 | In 22 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 22 days | ||
| General meeting for 2025 | 2026-05-28 | 3.02 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 3.02 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 3.02 (+0.00%) | ||
| Annual report for 2025 | 2026-04-03 | 3.02 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 16:30 | 3.02 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 3.02 (+0.00%) |
Show
Entries
MDxHealth SA Frequently Asked Questions
What is MDxHealth SA(LTS:0O8G)'s stock price today?
The current price of LTS:0O8G is €3.02. The 52 week high of LTS:0O8G is €3.02 and 52 week low is €3.02.
When is next earnings date of MDxHealth SA(LTS:0O8G)?
The next earnings date of MDxHealth SA(LTS:0O8G) is 2026-08-13.
Does MDxHealth SA(LTS:0O8G) pay dividends? If so, how much?
MDxHealth SA(LTS:0O8G) does not pay dividend.
Press Release
Articles on MDxHealth SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers